Caxton Associates (UK)’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Sell
90,858
-123,402
-58% -$2.92M 0.04% 228
2026
Q1
$4.68M Sell
214,260
-14,811
-6% -$343K 0.11% 75
2025
Q4
$5.33M Buy
229,071
+142,145
+164% +$3.43M 0.1% 61
2025
Q3
$2.46M Sell
86,926
-98,070
-53% -$2.61M 0.06% 154
2025
Q2
$4.07M Hold
184,996
0.1% 98
2025
Q1
$4.31M Buy
+184,996
New +$4.73M 0.15% 53

Other funds holding GNTX

Caxton Associates (UK)'s GNTX Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Gentex (GNTX) stake by 58% in Q2 2026, selling an estimated $2.92M and leaving 90,858 shares worth $2.3M. The position accounts for 0.04% of the portfolio, ranked #228.

Caxton Associates (UK) first reported a position in GNTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.33M in Q4 2025. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Caxton Associates (UK) held 90,858 shares of Gentex worth $2.3M as of Q2 2026.
  • Caxton Associates (UK) sold 123,402 Gentex shares in Q2 2026, an estimated $2.92M.
  • Gentex made up 0.04% of Caxton Associates (UK)'s portfolio in Q2 2026, its #228 holding.
  • Caxton Associates (UK) first reported a position in Gentex in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s Gentex position peaked at $5.33M in Q4 2025.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.